C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life. [electronic resource]
- Allergy and asthma proceedings
- 427-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1539-6304
10.2500/aap.2012.33.3597 doi
Acute Disease Adolescent Adult Angioedemas, Hereditary--drug therapy Child Complement C1 Inhibitor Protein--administration & dosage Female Humans Male Mental Health Middle Aged Prospective Studies Quality of Life Surveys and Questionnaires Treatment Outcome Young Adult